The expanding role of HLA gene tests for predicting drug side effects
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The expanding role of HLA gene tests for predicting drug side effects
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-10-12
DOI
10.1016/j.amjms.2023.10.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug‐Induced Liver Injury with Commonly Used Antibiotics in the All of Us Research Program
- (2023) Shaopeng Gu et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs
- (2023) Chih-Hsuan Wung et al. Frontiers in Pharmacology
- Relevance of Pharmacogenomics to the Safe Use of Antimicrobials
- (2023) Ann K. Daly Antibiotics-Basel
- Patients with naproxen‐induced liver injury display T‐cell memory responses toward an oxidative (S)‐O‐Desmethyl Naproxen metabolite but not the acyl glucuronide
- (2023) Paul Thomson et al. ALLERGY
- Liver Injury Associated with Turmeric—A Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network [DILIN]
- (2022) Dina Halegoua-DeMarzio et al. AMERICAN JOURNAL OF MEDICINE
- Integrating Coronary Atherosclerosis Burden and Progression with Coronary Artery Disease Risk Factors to Guide Therapeutic Decision Making
- (2022) Andrew M. Freeman et al. AMERICAN JOURNAL OF MEDICINE
- Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary Prevention
- (2022) Nicholas A. Marston et al. JAMA Cardiology
- Implementation of Pharmacogenomic Information on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
- (2021) Eri Tsukagoshi et al. Frontiers in Medicine
- A pediatric case of Stevens‐Johnson syndrome with acute liver failure, resulting in liver transplantation
- (2021) Michiru Totsuka et al. JOURNAL OF DERMATOLOGY
- Ibuprofen induced Stevens-Johnson syndrome and liver injury in children: a case report
- (2021) Ming-Zhu Gui et al. Translational Pediatrics
- Drug-Induced QTc Prolongation: What We Know and Where We Are Going
- (2021) Erinn Mangona et al. Current Drug Safety
- Advances and highlights in T and B cell responses to drug antigens
- (2021) Ruben Fernandez‐Santamaria et al. ALLERGY
- HLA-B*14:01 and HLA-B*35:01 are associated with trimethoprim-sulfamethoxazole induced liver injury
- (2020) Yi-Ju Li et al. HEPATOLOGY
- A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury
- (2019) Elizabeth T. Cirulli et al. GASTROENTEROLOGY
- Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management
- (2018) Zhining Wen et al. DRUG DISCOVERY TODAY
- PD-1 Inhibitor-associated Myopathies
- (2018) Teerin Liewluck et al. JOURNAL OF IMMUNOTHERAPY
- Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study
- (2017) Paola Nicoletti et al. GASTROENTEROLOGY
- A possible role for HLA-DRB1*04:06 in statin-related myopathy in Japanese patients
- (2016) Kimie Sai et al. Drug Metabolism and Pharmacokinetics
- Statin-Associated Autoimmune Myopathy
- (2016) Andrew L. Mammen NEW ENGLAND JOURNAL OF MEDICINE
- Integration of Genomics in Primary Care
- (2015) Eric A. Larson et al. AMERICAN JOURNAL OF MEDICINE
- HLA-B*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer
- (2015) C.-F. Xu et al. CLINICAL CANCER RESEARCH
- Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update
- (2015) Y Saito et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
- (2015) Naga Chalasani et al. GASTROENTEROLOGY
- Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01
- (2015) L R Parham et al. PHARMACOGENOMICS JOURNAL
- Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 Update
- (2014) M A Martin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Drug-Induced Liver Injury: Morbidity, Mortality, and Hy’s Law
- (2014) Arie Regev et al. GASTROENTEROLOGY
- Abacavir Pharmacogenetics - From Initial Reports to Standard of Care
- (2013) Michael A. Martin et al. PHARMACOTHERAPY
- HLA Alleles Influence the Clinical Signature of Amoxicillin-Clavulanate Hepatotoxicity
- (2013) Camilla Stephens et al. PLoS One
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing
- (2012) M S Hershfield et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing
- (2012) M A Martin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
- (2012) Dinesh Khanna et al. ARTHRITIS CARE & RESEARCH
- A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury
- (2010) Jonathan B Singer et al. NATURE GENETICS
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started